TrialCompass TCL
Back to results
Not yet recruitingPriority 4 · Lower priorityNCT07046663

Long-term Assessment of Chlormethine Gel in Mycosis Fungoides

ClinicalTrials.gov

Plain-language summary

This trial is studying a new treatment for people with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.

Who can join (key eligibility)

  • Age 18 Years or older
  • See full trial listing for complete eligibility

Final eligibility is determined by the trial team. This list is a starting point only.

What's being tested

Drugs / treatments
Treatment length
Ask the trial team for details
Visit frequency
Ask the trial team for details
TrialCompass — Clinical Trial Summary

Long-term Assessment of Chlormethine Gel in Mycosis Fungoides

NCT07046663

Phase: | Status: Not yet recruiting | Priority: Lower

Plain-language summary

This trial is studying a new treatment for people with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.

Who can join

  • Age 18 Years or older
  • See full trial listing for complete eligibility

What's being tested

Drugs / treatments:

Treatment length: Ask the trial team for details

Visit frequency: Ask the trial team for details

Trial design

Non-randomized, blind

Enrollment target: 190 patients

Primary endpoint: Rate of complete remission (rate CR)

Ages: 18 Years to —

Start date: 2025-09 | Est. completion: 2026-06

Locations

0 US sites · 20 total

Contact

Uffici Studi FIL | idemartino@filinf.it | +390131033153

Sponsor: Fondazione Italiana Linfomi - ETS (OTHER)

Tags

CTCL · any

View on ClinicalTrials.gov

https://clinicaltrials.gov/study/NCT07046663

Prepared using TrialCompass (trialcompass.com) on June 19, 2026. For informational purposes only. Always discuss with your healthcare team.